Rothschild & Co. Asset Management US Inc. increased its stake in shares of LHC Group, Inc. (NASDAQ:LHCG) by 1.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 455,678 shares of the health services provider’s stock after acquiring an additional 5,333 shares during the period. Rothschild & Co. Asset Management US Inc. owned about 1.45% of LHC Group worth $42,779,000 as of its most recent SEC filing.
Several other large investors also recently modified their holdings of LHCG. FMR LLC increased its stake in LHC Group by 297.8% in the 2nd quarter. FMR LLC now owns 1,151,406 shares of the health services provider’s stock valued at $98,548,000 after buying an additional 861,952 shares during the last quarter. Bank of New York Mellon Corp increased its stake in shares of LHC Group by 162.0% during the 2nd quarter. Bank of New York Mellon Corp now owns 711,508 shares of the health services provider’s stock worth $60,897,000 after purchasing an additional 439,947 shares during the last quarter. American Century Companies Inc. acquired a new position in shares of LHC Group during the 3rd quarter worth about $35,964,000. GW&K Investment Management LLC acquired a new position in shares of LHC Group during the 3rd quarter worth about $24,836,000. Finally, Redmile Group LLC acquired a new position in shares of LHC Group during the 3rd quarter worth about $22,398,000. Institutional investors and hedge funds own 90.50% of the company’s stock.
Shares of LHCG stock opened at $109.25 on Tuesday. The stock has a market cap of $3.43 billion, a P/E ratio of 45.14, a P/E/G ratio of 1.52 and a beta of 0.89. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 0.17. LHC Group, Inc. has a 52 week low of $59.21 and a 52 week high of $112.22.
Several research firms have recently weighed in on LHCG. William Blair restated a “buy” rating on shares of LHC Group in a research note on Thursday, November 1st. Zacks Investment Research upgraded shares of LHC Group from a “hold” rating to a “buy” rating and set a $105.00 price objective on the stock in a research note on Wednesday, January 2nd. Barclays began coverage on shares of LHC Group in a research note on Friday, December 14th. They set an “equal weight” rating and a $105.00 price objective on the stock. Craig Hallum lowered shares of LHC Group from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $99.00 to $92.00 in a research note on Friday, October 26th. Finally, Robert W. Baird boosted their price objective on shares of LHC Group from $95.00 to $98.00 and gave the stock a “neutral” rating in a research note on Friday, November 2nd. Four research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $105.77.
In related news, CEO Keith G. Myers sold 75,000 shares of LHC Group stock in a transaction dated Monday, December 3rd. The shares were sold at an average price of $103.40, for a total transaction of $7,755,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Jeff Reibel sold 5,239 shares of the business’s stock in a transaction dated Tuesday, December 4th. The shares were sold at an average price of $105.26, for a total transaction of $551,457.14. The disclosure for this sale can be found here. Insiders have sold a total of 241,821 shares of company stock valued at $24,422,790 in the last ninety days. 6.80% of the stock is currently owned by insiders.
TRADEMARK VIOLATION NOTICE: This news story was reported by The Lincolnian Online and is the property of of The Lincolnian Online. If you are reading this news story on another publication, it was illegally stolen and republished in violation of United States & international copyright & trademark law. The correct version of this news story can be viewed at https://www.thelincolnianonline.com/2019/02/12/lhc-group-inc-lhcg-shares-bought-by-rothschild-co-asset-management-us-inc.html.
About LHC Group
LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.
Read More: Capital Gains
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.